Stay updated with breaking news from Discovery Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Based on forthcoming completion of patient enrollment and duration of follow-up in Cohort 2 from the phase 2 trial in late-stage NSCLC
Nicoletta Loggia, PhD, RPh, biopharma executive with more than two decades of technical expertise in the biopharmaceutical industryNEEDHAM, Mass., June 08, 2023 -- Candel Therapeutics, Inc. , a... | June 8, 2023
Public-Private Partnership Secures $14 Million Funding for Fusion Power Industry Key Highlights First Light Fusion, the University of Oxford, the University of...
/PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets...
SAN JOSE, Calif., April 25, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets